MP
BMEZ icon

Mangrove Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Mangrove Partners’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-377,466
Closed -$6.2M – 377
2022
Q2 		$6.2M Buy
+377,466
New +$6.47M 0.3% 77

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
QC
Quantedge Capital Singapore $183M AUM 37.27% 1-Year Est. Return
COLIM
City of London Investment Management London, United Kingdom $1.38B AUM 42.43% 1-Year Est. Return

Mangrove Partners's BMEZ Position: Q3 2022 in Review

Mangrove Partners sold out of BlackRock Health Sciences Trust II (BMEZ) in Q3 2022, closing a stake of 377,466 shares — an estimated $6.2M sold.

Mangrove Partners first reported a position in BMEZ in Q2 2022 and held it in 1 quarter. The position peaked at $6.2M in Q2 2022. 75 funds tracked by Wall St. Rank hold BMEZ as of Q3 2022.

  • Mangrove Partners reported no remaining BlackRock Health Sciences Trust II position as of Q3 2022 after selling out during the quarter.
  • Mangrove Partners sold 377,466 BlackRock Health Sciences Trust II shares in Q3 2022, an estimated $6.2M.
  • Mangrove Partners first reported a position in BlackRock Health Sciences Trust II in Q2 2022 and held it in 1 quarter.
  • Mangrove Partners's BlackRock Health Sciences Trust II position peaked at $6.2M in Q2 2022.
  • 75 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2022.

Based on Mangrove Partners's 13F filing for Q3 2022, filed 14 Nov 2022.